RCA
MRNA icon

Roberts Capital Advisors’s Moderna MRNA Stock Holding History

Roberts Capital Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,067
Closed -$71.3K – 84
2024
Q3 		$71.3K Hold
1,067
– – 0.06% 89
2024
Q2 		$114K Hold
1,067
– – 0.11% 88
2024
Q1 		$114K Buy
+1,067
New +$108K 0.11% 88
2022
Q3 		$135K Hold
1,144
– – 0.2% 86
2022
Q2 		$163K Hold
1,144
– – 0.22% 85
2022
Q1 		$197K Hold
1,144
– – 0.2% 92
2021
Q4 		$291K Buy
+1,144
New +$334K 0.27% 91

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Roberts Capital Advisors's MRNA Position: Q4 2024 in Review

Roberts Capital Advisors sold out of Moderna (MRNA) in Q4 2024, closing a stake of 1,067 shares — an estimated $71.3K sold.

Roberts Capital Advisors first reported a position in MRNA in Q4 2021 and held it in 7 quarters. The position peaked at $291K in Q4 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Roberts Capital Advisors reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Roberts Capital Advisors sold 1,067 Moderna shares in Q4 2024, an estimated $71.3K.
  • Roberts Capital Advisors first reported a position in Moderna in Q4 2021 and held it in 7 quarters.
  • Roberts Capital Advisors's Moderna position peaked at $291K in Q4 2021.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Roberts Capital Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.